Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Por um escritor misterioso
Last updated 30 julho 2024
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Targeting RNA structures with small molecules
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
ACS Infectious Diseases
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Discovery of a Novel Class of Orally Active Trypanocidal N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
ACS Infectious Diseases
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Biochemical and structural evidence for the NMT activity on lysine a
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Water molecules in PDZ domains HTRA1, HTRA2, and HTRA3. Selectivity in
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
NMT inhibition results in loss of the inner membrane complex and
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Design and synthesis of inhibitors of Plasmodium falciparum N- myristoyltransferase, a promising target for antimalarial drug discovery. - Abstract - Europe PMC
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Cryptosporidiosis Drug Discovery: Opportunities and Challenges
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Frontiers Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Cryptosporidiosis Drug Discovery: Opportunities and Challenges

© 2014-2024 hellastax.gr. All rights reserved.